The Advisory Committee on Immunization Practices (ACIP) has announced a new review of long-approved vaccines and the cumulative effect of shots given to children and adolescents. Martin Kulldorff, the co-chair of the committee, made the announcement at a hearing in Atlanta following the replacement of former members by hand-picked panelists appointed by health secretary Robert F. Kennedy Jr.
The review will be conducted by two new work groups, with one focusing on the overall childhood and adolescent vaccine schedules and the other on vaccines that have been approved for seven or more years. Specifically mentioned were the hepatitis B shot given at birth and the combination measles, mumps, rubella, and chickenpox shot, which have been targeted by vaccine skeptics.
Kulldorff emphasized the importance of staying updated with scientific research to ensure that ACIP recommendations are optimal for both individuals and public health. This move comes in response to concerns raised by vaccine skeptics and anti-vaccine groups about the cumulative exposure to vaccines and potential harms, such as autism, a claim widely disputed by the scientific community.
The American Academy of Pediatrics (AAP) announced that they would no longer participate in the ACIP process, stating that the newly constituted committee was no longer credible. The AAP will continue to publish its own immunization schedule independently.
The ACIP has previously explored the safety of the vaccine schedule, with a recent analysis in 2023 finding a potential small association between aluminum exposure from vaccines and asthma. However, the overall evidence continues to support the safety of the routine childhood vaccination schedule.
In Washington, President Trump’s nominee for CDC director, Susan Monarez, expressed support for vaccines during her confirmation hearing. She addressed Kennedy’s decision to halt U.S. support for Gavi, the Vaccine Alliance, emphasizing the importance of vaccines in saving lives and promoting their utilization.
As the ACIP continues its review of long-approved vaccines and the impact of the vaccine schedule on children and adolescents, the scientific community and public health experts remain committed to evidence-based medicine and ensuring the safety and effectiveness of vaccinations.
